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ABSTRACT   
 
BACKGROUND: Metabolic syndrome is a major health problem 
worldwide. Globally, the World Health Organization identified 
physical inactivity as the fourth leading risk factor for mortality. 
This study was conducted to evaluate the association between 
physical activities and metabolic syndrome and diabetes 
complications among type 2 diabetes patients in Gaza Strip, 
Palestine. 
METEHODS: This cross-sectional study was conducted among 
1200 previously diagnosed type 2 diabetes mellitus patients (from 
both genders, aged 20 to 64 years) receiving care in the primary 
health care centers. Metabolic syndrome was defined based on the 
International Diabetes Federation criteria. The International 
Physical Activity Questionnaire was used to measure physical 
activity. Statistical analysis was performed using SPSS version 20. 
RESULTS: A significant inverse association was found between 
inactive patients and metabolic syndrome. In our study, 93.7% of 
inactive patients, 66.4% of active patients and 23.5% of very active 
patients had metabolic syndrome (OR .048 CI 95% (.03-.072)), (OR 
.787 CI 95% (.59-1.03)) and (OR 15.9 CI 95% (11.8-21.3)) 
respectively. Our results showed a significant inverse association 
between physical activity levels and anthropometric measurements 
in both gender. Moreover, a significant association was found 
between physical activity levels and triglycerides, HDL-cholesterol 
and blood pressure in both sexes (P value < 0.05 for all) and 
diabetes complications (P value < 0.05 for all). 
CONCLUSION: We conclude that low levels of physical activity 
are associated with increased prevalence of metabolic syndrome. 
Furthermore, inactive patients had a high percentage of diabetes 
complications among type 2 diabetes patients in Gaza Strip, 
Palestine. 
KEYWORDS: Physical activity, metabolic syndrome, type 2 
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Metabolic syndrome (MetS) is a cluster of the 
most dangerous heart attack risk factors: diabetes 
and raised fasting plasma glucose (FPG), 
abdominal obesity, high cholesterol and high 
blood pressure (BP) (1,2,3). MetS is a major 
health problem worldwide; it is estimated that 
around 20 to 25 percent of the world’s adult 
population have MetS, and mortality rate in these 
people is twice as likely from heart attack, and 
three times as likely from stroke compared with 
people without MetS (4). The underlying causes of 
the MetS have been suggested as central obesity 
and insulin resistance (5,6). In addition, genetics, 
physical inactivity, ageing, proinflammatory state 
and hormonal changes may also have causal 
effects, but the role of these may vary depending 
on ethnic groups (7,8). Physical inactivity is an 
independent risk factor for chronic diseases which 
is estimated to cause 1.9 million deaths, globally 
(9,10,11). Moreover, physical inactivity is 
considered as the fourth leading risk factor for 
global mortality causing an estimated 3.2 million 
annual deaths (6% of global deaths) (12). Physical 
activity (PA) decreases the risk for premature 
death, coronary artery disease, obesity, diabetes, 
hypertension (HTN), cancer and depression 
thereby lowering medical and medication costs 
and improving quality of life (13). The fact that 
the lack of PA and MetS is cardiovascular risk 
factors that increase overall morbidity makes the 
study of their interrelationships extremely 
important. Moreover, low levels of PA are 
strongly associated with the development of MetS 
and chronic diseases. To the best of our 
knowledge, this is the first study, which examined 
this association among type 2 diabetes mellitus 
(T2DM) patients in Gaza Strip, Palestine. the 
study was conducted to evaluate the association 
between PA and the MetS among T2DM patients 
in Gaza Strip, Palestine, and to examine the 
association between PA and diabetes 
complications. 
 
MATERIALS AND METHODS 
 
Study design and sampling technique: This 
cross-sectional study was conducted in the years 
2015 and 2016 among a representative sample of 
Palestinian T2DM patients, selected through 
cluster random sampling method. A total of 1200 
patients (from both gender, aged 20 to 64 years) 
receiving care in the primary health care centers 
(PHCs) in Gaza Strip, Palestine, were included in 
the study. Gaza Strip is divided into five smaller 
governorates, which include North Gaza, Gaza 
City, Mid Zone, Khan Younis and Rafah. The 
total number of PHCs in Gaza Strip is fifty-four 
(14). The PHCs were distributed in each 
governorate as follows (eight, fourteen, sixteen, 
eleven and five respectively). The study sample 
was distributed according to the number of PHCs 
in each governorate as follows (178, 311, 356, 244 
and 111 patients respectively). Pregnant women, 
lactating women and patients with other types of 
serious illness such as cancer, acute myocardial 
infarction or end stage kidney disease were 
excluded from the study.  
 
Assessment of blood pressure and 
anthropometric measures: BP was measured 
from the left arm (mmHg), by mercury 
sphygmomanometer, three readings on different 
days. While the patient was seated after relaxing 
for at least 15 minutes in a quiet environment, 
empty bladder. The average of three 
measurements was recorded. Weight was 
measured with the use of a Seca scale and 
recorded to the nearest 0.1 kg. Height was 
measured with a Seca studiometer while subjects 
were standing with their shoulders positioned 
normally. The body mass index (BMI) was 
calculated as the weight in kilograms divided by 
the height in meters square. Waist circumference 
(WC) was measured at the narrowest level 
between the lowest rib and the iliac crest with the 
use of an outstretched tape measure. 
Measurements were recorded to the nearest 0.5 
cm. After calculating BMI, individuals were 
categorized into underweight, healthy weight, 
overweight and obese using WHO cut-off point 
(15). 
 
Assessment of biomarkers: After 12 hours 
fasting, a venous blood samples was collected 
from all patients in the primary health care centers 
(in the second meeting with the patients), by well-
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trained and experienced nurses. Venous blood (4.0 
ml) was drawn into vacationer tubes and was used 
for blood chemistry analysis. Serum was separated 
immediately and the extracted serum was 
investigated for (FPG mg/dl, High Density 
Lipoprotein cholesterol (HDL-c) mg/dl and 
triglycerides (TGs) mg/dl). Mindray BS-300 
chemistry analyzer instrument was used for blood 
chemistry analysis. The laboratory tests were 
analyzed in private licensed laboratory. 
 
Assessment of other variables: Data on PA were 
obtained using the International Physical Activity 
Questionnaire (IPAQ short version) (16). The 
internationally accepted protocol was used to 
estimate the weekly calorie expenditure expressed 
as metabolic equivalents per week (MET/wk) or 
converted to kcal/wk using the formula kcal = 
MET × weight ÷ 60. The IPAQ scoring protocol 
assigns the following MET values to walking, 
moderate and vigorous intensity activity: 3.3 
METs, 4.0 METs, and 8.0 METs, respectively. 
According to the IPAQ scoring protocol, the 
patients were classified based on their weekly 
energy expenditure as follows: Insufficiently 
Active (IA) ≤600 MET/wk; Sufficiently Active 
(SA) 601 to 1500 MET/wk; and Very Active (VA) 
≥1500 MET/wk (17). Additional covariate 
information regarding age, medical history and 
diabetes complications was obtained with an 
interview-based questionnaire. Before the data 
collection, pilot study was carried out on thirty 
patients to enable the researcher to examine the 
tools of the study. The questionnaire and the data 
collection process were modified according to the 
result of the pilot study. The data was collected by 
ten qualified data collectors who were given 
explanation and training by the researcher about 
the study, its purpose, objectives, procedures and 
ways of distributing and collecting the 
questionnaire with respect to confidentiality. 
 
Definition of MetS: MetS was defined according 
to the International Diabetes Federation (IDF) 
definition (2). 
 
Statistical analysis: All statistical analyses were 
performed using Statistical Package for Social 
Science (SPSS) version 20. The descriptive 
statistics of mean, standard deviation and 
percentages were calculated for the entire sample. 
Chi-square test was used to examine differences in 
the prevalence of different categorical variables. 
The differences between means were tested by 
independent samples t-test and one-way ANOVA. 
The odds ratio (OR) and the confidence interval 
(CI) for the presence of MetSat, different PA 
levels were calculated. P value less than 0.05 was 
considered as statistically significant. 
 
Ethical issues: The study protocol was approved 
by the Ethics Committee of Tehran University of 
Medical Sciences (Code: IR.TUMS.REC.1394.58) 
and by the Palestinian Health Research Council 
(Helsinki Ethical Committee of Research 
PHRC/HC/60/15). Furthermore, written informed 
consent was obtained from the study participants 




A total of 1200 patients with T2DM aged 20 to 64 
years old (59.8% females, 40.2% males) were 
included in this study. Table 1 shows the 
characteristics of the study population by sex in 
relation to the presence of MetS and its absence 
(According to IDF definition). Our findings 
demonstrate that the mean age for males with 
MetS was 55.3±6.9 vs. 42.6±10.1 in the non-MetS 
group; the mean age for females with MetS is 
55.5±6.9 and 38.0±9.6 in the non-MetS group. In 
addition, Table 1 shows that for the following risk 
factors (Age, BMI, central obesity, high BP, high 
TGs and low HDL-c), the difference was 
statistically significant in both sexes (P value < 
0.05). Then, we examined the relationship 
between MetS and medical history factors (Table 
2). A significant inverse association was found 
between diabetes duration, BMI and the MetS (P 
value < 0.05). In addition, our findings showed 
that 48.4% of the patients with MetS received 
diabetes care instructions, all patients (100%) used 
diabetes medications, 91.4% of the patients with 
MetS used pills and nsulin injections, 54.9% were 
smokers, no patients consumed alcohol and most 
of female patients with MetS (89.5%) were post- 
menopause. For these risk factors, the difference 
was statistically significant between T2DM 
patients with and without MetS (P value < 0.05). 
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In addition, we concluded in Table 3 that the mean 
weekly metabolic energy expenditure expressed as 
MET/wk for males with MetS was 905.2±9 vs. 
2729.8±1 in males without MetS. The mean for 
females with MetS was 710.6±1 MET/wk and 
2293.2±1 MET/wk in females without MetS. And 
the difference was statistically significant between 
the MetS and non-MetS groups in both sexes (P 
value < 0.05, T value = 5.903). The obtained 
results showed that the mean energy expenditure, 
which includes the body weight in its formula and 
is expressed in kcal/wk for males with MetS, was 
1413.7±1 vs. 3465.3±2 in males without MetS. 
The mean for females with MetS is 1028.1±1 
kcal/wk and 2564.3±1 kcal/wk in females without 
MetS and the difference was statistically 
significant between the MetS and non-MetS 
groups in both sexes (P value < 0.05, T value = 
7.041). Also, we found a significant inverse 
association between PA levels (IA, SA and VA) 
and the incidence of MetS in both sexes (P value < 
0.05). Furthermore, our findings demonstrated that 
there was a significant inverse association between 
PA levels and anthropometric measurements such 
as BMI and WC for males and females (P value < 
0.05) as shown in Table 4. In addition, we found a 
significant association between PA levels and TGs 
(P value < 0.01), HDL-c (P value < 0.01) and BP 
(P value < 0.01) in males and females. With 
respect to FPG, we found a significant association 
between PA levels and FPG in males (P value < 
0.05), but in females, the difference did not reach 
a statistical significant level (P value = 0.360). 
Also, we computed the OR and the CI of the MetS 
atdifference PA levels (IA, SA & VA) (Table 5). 
Our findings demonstrated that 93.7% of IA 
patients had MetS OR .048 CI 95% (.03-.072), 
66.4% of SA patients had MetS OR .787 CI 95% 
(.59-1.03) and 23.5% of VA patients had MetS 
OR 15.9 CI 95% (11.8-21.3). Finally, we 
examined the relationship between PA levels (IA, 
SA and VA) and diabetes complications (Eye 
problems, kidney problems, protein in urine, heart 
problems, extremities problems and neurological 
problems). Table 6 shows that there was a 
significant association between PA levels and 
diabetes complications (P value < 0.05). Finally, a 
significant association was found between 
diabetes complications (Eye problems, kidney 
problems, protein in urine, heart problems, 
extremities problems and neurological problems) 
and the prevalence of MetS in our study 
population (P value < 0.05). 
 


















Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Age (years) 49.74±11.07 55.3±6.9 42.6±10.1 .001 55.5±6.9 38.0±9.6 .001 
BMI (kg/m²) 30.22±6.28 31.1±4.5 25.0±3.6 .001 34.2±5.9 25.4±3.4 .001 
Central obesity 985 (82.08%) 258 (100%) 57 (25.4%) .001 490 (100%) 180 (78.9%) .001 
High BP 771 (64.25%) 250 (96.8%) 39 (17.4%) .001 481 (98.1%) 1 (0.4%) .001 
High triglycerides 504 (42%) 154 (59.6%) 8 (3.5%) .001 341 (69.5%) 1 (0.4%) .001 
Low HDL-c 487 (40.58%) 138 (53.4%) 8 (3.5%) .001 340 (69.3%) 1 (0.4%) .001 
In our study, all participants previously diagnosed T2DM 
 
Central obesity was defined as waist circumference ≥ 94 cm in men and ≥ 80 cm in women. High blood pressure was  
≥ 130/85 mmHg or treatment of previously diagnosed hypertension. High triglyceride was ≥150 mg/dl or specific 
treatment for this lipid abnormality. Low high-density lipoprotein cholesterol was <40 mg/dl in males and <50 mg/dl 
in females or specific treatment for this lipid abnormality. 
The differences between means were tested by using independent sample t test. Descriptive statistics, Crosstabs, the 
chi-square test were used to examine difference in the prevalence of different categorical variables. P value less than 
0.05 was considered as statistically significant. 
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No. % No. % No. % 
Diabetic duration Less than five 72 22.8 244 77.2 316 100  
.001 Five to ten 274 63.1 160 36.9 434 100 
More than ten 402 89.3 48 10.7 450 100 
BMI category Under weight 0 0.0 7 100.0 7 100  
 
.001 
Healthy weight 36 13.8 225 86.2 261 100 
Over weight 186 50.8 180 49.2 366 100 
Obesity  526 92.9 40 7.1 566 100 
Family history of diabetes Yes 640 62.7 380 37.3 1020 100  
.483 No  108 60.0 72 40.0 180 100 
Received DM care 
instructions 
Yes 278 48.4 296 51.6 574 100  
.001 No  470 75.1 156 24.9 626 100 
Use DM medications Yes 748 62.3 452 37.7 1200 100 - 
Type of diabetes 
medications used 
Diabetes pills 243 49.5 248 50.5 491 100  
.001 Insulin injections 431 68.6 197 31.4 628 100 
Pills & injections 74 91.4 7 8.6 81 100 
Smoking Yes 89 54.9 73 45.1 162 100  
.001 No  659 63.5 379 36.5 1038 100 
Consume alcohol No 748 62.3 452 37.7 1200 100 - 
Females menopausal status Premenopausal 40 18.6 175 81.4 215 100  
.001 Postmenopausal 450 89.5 53 10.5 503 100 
Male 258 53.5 224 46.5 482 100 
Descriptive statistics, Crosstabs, the chi-square test was used to examine difference in the prevalence of different 
categorical variable. P value less than 0.05 was considered as statistically significant. 
 
Table 3: Distribution of weekly energy expenditure, PA levels and weekly PA duration by sex in relation to the 
presence of MetS or its absence. 
 
 














Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Weekly energy expenditure  
MET/wk 1430.1±1519.2 905.2±965 2729.8±1762 .001 710.6±1054 2293.2±1357 .001 
Kcal/wk 1857.8±1965.7 1413.7±1766 3465.3±2352 .001 1028.1±1483 2564.3±1393 .001 
Physical activity levels (MET/wk) 
IA (≤ 600) 476 (39.6%) 128 (86.5%) 20 (13.5%)  
.001 
318 (97.0%) 10 (3.0%)  
.001 SA (601 to 1500) 307 (25.5%) 88 (67.7%) 42 (32.3%) 116 (65.5%) 61 (34.5%) 
VA (≥1500) 417 (34.75%) 42 (20.6%) 162 (79.4%) 56 (26.3%) 157 (73.7%) 
 
MET/wk: Weekly energy expenditure in metabolic equivalents per wk. 
Kcal/wk: Weekly energy expenditure in kilocalories = MET * weight (kg) / 60. 
IA= Insufficiently Active; SA= Sufficiently Active; VA= Very Active. 
The differences between mean were tested by using independent sample T test and one-way ANOVA. P value less 
than 0.05 was considered as statistically significant. 
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 Mean ± SD Mean ± SD Mean ± SD  Mean ± SD Mean ± SD Mean ± SD  
BMI (kg/m²) 31.0±4.6 28.8±4.7 25.9±4.6 .001 35.1±6.0 30.5±5.2 26.7±5.1 .001 
WC (cm) 110.4±12.3 104.1±13.2 92.6±12.1 .001 117.2±13.7 105.3±15.0 93.1±16.2 .001 
FPG (mg/dl) 171.4±29.1 171.3±29.1 164.7±24.9 .031 169.9±33.4 173.0±27.9 168.7±26.4 .360 
TGs (mg/dl) 188.2±57.5 157.9±48.9 127.1±20.7 .001 193.7±50.6 150.4±43.8 131.4±43.2 .001 
HDL-c(mg/dl) 37.9±6.1 41.8±5.6 46.1±4.2 .001 41.1±7.2 49.5±7.6 53.5±6.2 .001 
SBP (mmHg) 138.9±9.6 134.3±10.2 122.3±8.2 .001 141.2±9.0 130.7±11.0 121.7±9.9 .001 
DBP (mmHg) 87.4±6.0 86.0±5.5 79.2±5.6 .001 89.3±5.7 83.2±7.2 78.3±6.9 .001 
 
Activity level category measured in metabolic equivalents per week (MET/wk): IA= insufficiently active (≤600 
MET/wk); SA= sufficiently active (601 to 1500 MET/wk); and VA= very active (≥1500 MET/wk). 
BMI= body mass index; WC= waist circumference; FPG= fasting plasma glucose; TGs= triglycerides; HDL-c= high-
density lipoprotein-cholesterol; SBP= systolic blood pressure; DBP= diastolic blood pressure.   
The differences between mean were tested by using independent sample T test and one-way ANOVA. P value less 
than 0.05 was considered as statistically significant. 
 
Table 5: Odds ratios of having MetS at different PA levels (According to IDF definition). 
 
 
Parameters MetS Total     P OR 
(95%CI) 
Presence Absence No % 
Insufficiently active (≤ 600 MET/wk) Yes 446 (93.7%) 30 (6.3%) 476 100  
.001 
 
.048 (.03-.072) No 302 (41.7%) 422 (58.3%) 724 100 




No 544 (60.9%) 349 (39.1%) 893 100 
Very active (≥ 1500 MET/wk) Yes 98 (23.5%) 319 (76.5%) 417 100  
.001 
 
15.9 (11.8-21.3) No 650 (83.0%) 133 (17.0%) 783 100 
 
MET/wk: metabolic equivalents per week 
The presence of MetS at different PA levels was calculated, using odds ratio and confidence interval of each risk 
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Table 6: Distribution of the study population by diabetes complications variables in relation to the presence of MetS or 






Activity level category  
P 











No. % No. % No. % No. % No. % No. % 
Eye problems Yes 348 73.1 161 52.4 185 44.4  
.001 
518 74.6 176 25.4 694 100  
.001 No 128 26.9 146 47.6 232 55.6 230 45.5 276 54.5 506 100 
Kidney 
problems 
Yes 89 18.7 23 7.5 18 4.3  
.001 
122 93.8 8 6.2 130 100  
.001 No 387 81.3 284 92.5 399 95.7 626 58.5 444 41.5 1070 100 
Protein in 
urine 
Yes 361 75.8 159 51.8 118 28.3  
.001 
512 80.3 126 19.7 638 100  
.001 No 115 24.2 148 48.2 299 71.7 236 42.0 326 58.0 562 100 
Heart 
problems 
Yes 59 12.4 14 4.6 14 3.4  
.001 
84 96.6 3 3.4 87 100  
.001 No 417 87.6 293 95.4 403 96.6 664 59.7 449 40.3 1113 100 
Extremities 
problems 
Yes 187 39.3 54 17.6 23 5.5  
.001 
235 89.0 29 11.0 264 100  
.001 No 289 60.7 253 82.4 394 94.5 513 54.8 423 45.2 936 100 
Neurological 
problems 
Yes 467 98.1 286 93.2 353 84.7  
.001 
721 65.2 385 34.8 1106 100  
.001 No 9 1.9 21 6.8 64 15.3 27 28.7 67 71.3 94 100 
 
Activity level category measured in metabolic equivalents per week (MET/wk): IA= insufficiently active (≤600 
MET/wk); SA= sufficiently active (601 to 1500 MET/wk); and VA= very active (≥1500 MET/wk). 
Descriptive statistics, Crosstabs, the chi-square test was used to examine difference in the prevalence of different 




To the best of our knowledge, this is the first 
report, which describes the relationship between 
PA and MetS among T2DM patients in Gaza 
Strip, Palestine. The main findings of this study 
indicate that low levels of PA are associated with 
increased prevalence of MetS. Many previous 
studies suggest that we should expect a higher 
number of IA individuals in the MetS patients 
(18,19). Katzmarzyk et al. (20) found that PA 
reduced the risk for MetS among black and white 
women and men in Canada. Other studies have 
consistently found an inverse association between 
PA and the lack of MetS among middle-aged 
white men in the United States (21), middle-aged 
and older men and women in China (22) and adult 
men and women in Australia (23). Moreover, 
Panagiotakos et al. (24) evaluated the association 
between PA and the prevalence of MetS among 
Greek adults. The author showed that even light to 
moderate leisure time PA was associated with a 
considerable reduction in the prevalence of MetS 
in 3042 men and women from the general 
population. The results of this study support these 
findings. In addition, according to the IPAQ 
scoring protocol, the patients were classified based 
on their weekly energy expenditure as follows: IA, 
SA and VA (17). Roberta et al. (25) used the same 
method to investigate the levels of PA in patients 
with and without MetS. The author concluded that 
patients with MetS presented the same levels of 
PA as the individuals who did not have MetS. Our 
study also showed a significant inverse association 
between PA levels and anthropometric 
measurements such as BMI and WC for both 
sexes. Ohkawara et al. (26) in a systematic review 
found a dose-response effect between an increase 
in PA and decrease in visceral fat. Rennie et al. 
(27) similarly found an inverse relationship 
between PA and BMI and WC. Panagiotakos et al. 
(24) found that MetS subjects who were sedentary, 
both males and females, were having high WC 
compared to them with moderate PA. According 
to BMI classification results, obesity was more 
prevalent in subjects having sedentary PA 
compared to moderate physically active MetS 
subjects. Moreover, we found a significant 
association between PA levels and TGs, HDL-c 
and BP in both sexes (P value < 0.05). The 
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literature strongly supports the benefits of exercise 
and PA in the prevention of MetS and T2DM. 
Increased PA promotes weight loss, improves 
insulin sensitivity, increases HDL-c levels, lowers 
TGs levels and prevents hypertension 
(28,29,30,31), which are considered the main 
components of MetS. Finally, according to the 
results of this study, there were significant inverse 
associations between PA and diabetes 
complications including eye problems, kidney 
problems, protein in urine, heart problems, 
extremities problems and neurological problems 
among T2DM patients. Many previous studies 
show that a regular PA may prevent or delay 
diabetes and its complications (32,33,34). 
Moreover, the available data show that a higher 
degree of diabetes complication is associated with 
lower PA levels (35,36). The main limitations of 
our study include its cross-sectional design, the 
fact that the causal relationship could not be fully 
determined and the possibility of recall bias by 
using questionnaire-based assessment of PA. The 
main strength of this study was being the first 
study, which describes the relationship between 
PA and MetS among T2DM patients in Gaza 
Strip, Palestine, and its large sample size. 
We conclude that low levels of PA are 
associated with increased prevalence of MetS. In 
addition, insufficiently active patients had a high 
percentage of diabetes complications among 
T2DM patients in Gaza Strip, Palestine. 
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